Research ArticleContinuing Education
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
Journal of Nuclear Medicine September 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
Jorge A. Carrasquillo
1Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York;
2Molecular Imaging Branch, National Cancer Institute, Bethesda, Maryland;
Clara C. Chen
3Department of Radiology, Clinical Center, National Institutes of Health, Bethesda, Maryland;
Abhishek Jha
4Section on Medical Neuroendocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; and
Karel Pacak
4Section on Medical Neuroendocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; and
Daniel A. Pryma
5Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania
Frank I. Lin
2Molecular Imaging Branch, National Cancer Institute, Bethesda, Maryland;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 9
September 1, 2021
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma, Frank I. Lin
Journal of Nuclear Medicine Sep 2021, 62 (9) 1192-1199; DOI: 10.2967/jnumed.120.259697
Jump to section
Related Articles
Cited By...
- No citing articles found.